Suchergebnisse - "Ziepert, Marita"

PubPharm (71)

1

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) : a randomised, phase 3, non-inferiority trial

enthalten in: Lancet (London, England) | 2019

von Poeschel, V. | Held, G. | Ziepert, M. | +43

CommentIn: Lancet. 2020 Dec 21;394(10216):2208-2209. - PMID 31868615

2

ALK-positive anaplastic large-cell lymphoma in adults : an individual patient data pooled analysis of 263 patients

enthalten in: Haematologica | 2019

von Sibon, D. | Nguyen, D. | Schmitz, N. | +15

3

The impact of SOCS1 mutations in diffuse large B-cell lymphoma

enthalten in: British journal of haematology | 2019

von Mellert, K. | Martin, M. | Lennerz, J. | +15

4

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma : A Study by the Lunenburg Lymphoma Biomarker Consortium

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Rosenwald, A. | Bens, S. | Advani, R. | +33

5

IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications

enthalten in: Virchows Archiv | 2019

von Granai, M. | Amato, T. | Di Napoli, A. | +13

6

IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications

enthalten in: Virchows Archiv | 2019

von Granai, M. | Amato, T. | Di Napoli, A. | +13

7

IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications

enthalten in: Virchows Archiv | 2019

von Granai, M. | Amato, T. | Di Napoli, A. | +13

8

Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial

enthalten in: British journal of haematology | 2019

von Friedrichs, B. | Nickelsen, M. | Ziepert, M. | +12

9

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) : a randomised, phase 3, non-inferiority trial

enthalten in: The lancet | 19 December 2019

von Pöschel, V. | Held, G. | Ziepert, M. | +41

10

Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

enthalten in: Blood | 2018

von Thurner, L. | Preuss, K. | Bewarder, M. | +26

CommentIn: Blood. 2018 Dec 27;132(26):2704-2706. - PMID 30591542

1
2
3
4
5
6
7
8
Nächster »
[8]